Dahap, Jerzelie .
HRN: 22-25-70 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2022
CEFUROXIME 500MG (TAB)
11/29/2022
12/05/2022
PO
500mg
BID
UTI
Waiting Final Action
11/29/2022
CEFUROXIME 1.5GM (VIAL)
11/29/2022
11/30/2022
IVT
1.5gm X 6 Doses
Q8
UTI
Waiting Final Action